MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Lewy bodies"

  • 2018 International Congress

    Papez circuit atrophy in Dementia with Lewy Bodies

    E. Matar, S. Wong, R. Tan, O. Piguet, M. Hornberger, J. Krill, J. Hodges, G. Halliday (Sydney, Australia)

    Objective: In this ex-vivo study, we aimed to assess atrophy in regions and subregions of the Papez Circuit, a network important for memory function, in…
  • 2018 International Congress

    Characterization of color vision impairment in Lewy Body Diseases

    T. Tousi, F. Flanigan, K. Khosravi (Cleveland, OH, USA)

    Objective: We sought to characterize the prevalence of color vision impairment in DLB patients and investigate how color vision impairment in DLB patients was associated…
  • 2018 International Congress

    Lewy body disease with visual hallucination: Optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

    M. Miyata, S. Kakeda, T. Yoneda, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We assessed structural abnormalities of optic radiation (OR) in healthy subjects (HS) and dementia with lewy body (DLB) patients (with visual hallucination) (VH) on…
  • 2018 International Congress

    Prevalence and influence of co-pathologies in patients with autopsy-confirmed Lewy body disorders: A systematic review

    D. Breen, E. Ravid, A. Lang, J. Miyasaki, R. Camicioli (Toronto, ON, Canada)

    Objective: To determine the prevalence of selected co-pathologies in patients with Lewy Body disorders, as well as their influence on disease expression. Background: The presence…
  • 2018 International Congress

    Submandibular gland is a suitable tissue for alpha synuclein pathology in Parkinson’s disease

    JH. Shin, SH. Park, CW. Shin, JH. Kim, TJ. Yun, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To validate the role of α-synuclein (AS) pathology in submandibular gland (SMG) as a biomarker for Parkinson disease (PD). Background: The pathologic hallmark of…
  • 2018 International Congress

    Are Lewy bodies associated with sympathetic pathology in dementia subjects?

    D. Shprecher, M. Callan, B. Cutler, G. Serrano, C. Adler, H. Shill, J. Caviness, M. Sabbagh, C. Belden, E. Driver-Dunckley, S. Mehta, L. Sue, K. Davis, E. Zamrini, T. Beach (Sun City, AZ, USA)

    Objective: Determine if Alzheimer disease (AD) subjects with Lewy bodies show sympathetic cardiac denervation. Background: Comorbid Lewy body (LB) pathology is very common in AD,…
  • 2018 International Congress

    LRRK2 p.Leu119Pro and p.Leu488Pro in a family with neuropathologycally confirmed Parkinson´s disease without Lewy bodies

    L. Vela-DeSojo, J. Hoenicka, P. Pire-Garcia, C. Guerrero, M. Osuna-Lopez, S. Ocaña-Lopez (Alcorcón, (Madrid), Spain)

    Objective: To describe the clinical features, genetic analysis and brain pathology of some members of a family affected by Parkinson´s disease. Background: Mutations of the…
  • 2018 International Congress

    Parkinson’s disease anxiety is associated with Lewy bodies in the Anterior Cingulate

    N. Fischer, J. Hinkle, K. Perepezko, G. Pontone (Baltimore, MD, USA)

    Objective: The goal of this study is to determine if there is an association between anxiety and the presence and regional distribution of Lewy bodies…
  • 2017 International Congress

    Targeting alpha-Synuclein Aggregation for the Treatment of Parkinson’s Disease

    E. Tsika, E. Gabellieri, A. Davranche, C. Boudou, M. Ravache, L. Grasso, S. Nampally, H. Haddouk, J. Wettstein, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

    Objective: To develop small molecular weight compounds (SMEs) as disease-modifying agents, which are designed to arrest or even reverse the aggregation process of alpha-synuclein (aSyn)…
  • 2017 International Congress

    Impaired Color Vision in Patients with DLB or Prodromal DLB.

    B. Tousi, P. Flanigan, M. Khosravi (Cleveland, OH, USA)

    Objective: We sought to characterize the prevalence of color vision impairment in DLB patients and investigate how color vision impairment in DLB patients was associated with other…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley